Blend Labs (NYSE:BLND) Price Target Lowered to $5.00 at Citizens Jmp

Blend Labs (NYSE:BLNDGet Free Report) had its price objective reduced by Citizens Jmp from $7.00 to $5.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “market outperform” rating on the stock. Citizens Jmp’s price target would suggest a potential upside of 205.81% from the stock’s previous close.

Several other equities analysts have also commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Blend Labs in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a research report on Sunday, November 16th. Four equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $4.47.

Check Out Our Latest Stock Analysis on BLND

Blend Labs Stock Performance

NYSE BLND opened at $1.64 on Wednesday. Blend Labs has a 52-week low of $1.57 and a 52-week high of $4.49. The company has a market capitalization of $424.69 million, a P/E ratio of -16.35 and a beta of 1.27. The company has a fifty day moving average of $2.33 and a 200-day moving average of $3.02.

Blend Labs (NYSE:BLNDGet Free Report) last released its earnings results on Tuesday, March 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.04). The company had revenue of $32.37 million during the quarter, compared to analyst estimates of $31.78 million. As a group, analysts forecast that Blend Labs will post -0.19 EPS for the current fiscal year.

Insider Transactions at Blend Labs

In other news, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction that occurred on Thursday, January 15th. The stock was sold at an average price of $3.06, for a total value of $76,500.00. Following the sale, the insider directly owned 649,824 shares in the company, valued at approximately $1,988,461.44. This trade represents a 3.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last quarter, insiders sold 33,125 shares of company stock worth $93,169. 35.52% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd bought a new stake in shares of Blend Labs during the 3rd quarter valued at about $32,000. Captrust Financial Advisors purchased a new position in shares of Blend Labs during the 2nd quarter worth approximately $35,000. South Shore Capital Advisors purchased a new position in shares of Blend Labs in the 4th quarter valued at approximately $36,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Blend Labs during the second quarter valued at approximately $37,000. Finally, Savvy Advisors Inc. purchased a new stake in Blend Labs in the third quarter worth $37,000. 52.56% of the stock is owned by hedge funds and other institutional investors.

Blend Labs News Roundup

Here are the key news stories impacting Blend Labs this week:

  • Positive Sentiment: $50 million share buyback announced, which supports share demand and signaled management confidence. Blend Labs stock climbs after $50M stock buyback
  • Positive Sentiment: Revenue slightly beat expectations: $32.37M reported vs. $31.78M consensus, showing top‑line momentum in Q4. Press Release
  • Positive Sentiment: CEO Nima Ghamsari expressed strong confidence in the business (“I have never been more excited”), which can support sentiment and long‑term investor conviction. CEO statement coverage
  • Neutral Sentiment: Street consensus remains cautious — analysts’ average rating is “Hold,” limiting upside from upgrades. Analyst ratings
  • Negative Sentiment: Q4 EPS missed estimates: reported ($0.03) vs. $0.01 expected, a clear near‑term profitability concern. Earnings details
  • Negative Sentiment: Q1 2026 revenue guidance ($28.5M–$30.0M) falls below the consensus (~$31.9M), creating downside risk for near‑term growth expectations. Preliminary results & guidance
  • Negative Sentiment: The stock has already traded down substantially (~46% decline noted in coverage), which raises volatility risk despite the buyback. Market reaction coverage

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.

Read More

Analyst Recommendations for Blend Labs (NYSE:BLND)

Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.